Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation-Reference-Cited by-同舟云学术

Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

Published:2022-05-25 Issue:8 Volume:57 Page:1341-1343
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Fernandez-Sojo Jesus^ORCID,Cid Joan^ORCID,Azqueta Carmen,Valdivia Elena,Martorell Lluis,Codinach Margarita,Marsal Julia,Mussetti Alberto,Esquirol Albert^ORCID,Trabazo Maria,Benitez Maria Isabel,Ferra Christelle^ORCID,Fox Maria Laura^ORCID,Linares Mónica,Alonso Eva,García-Rey Enric,García-Muñoz Nadia,Medina Laura,Castillo-Flores Nerea,Vall-Llovera Ferran,Garcia Antoni,Pinacho Asuncion,Talarn Carme,Arroba Jose Garcia,Coll Rosa,Santos Mireia,Valero Oliver,Carreras Enric,Lozano Miquel^ORCID,Querol Sergio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01722-6.pdf

Reference10 articles.

1. Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, et al. Indications for alloand auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transpl. 2019;54:1525–52.

2. Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bathia M, et al. Number of viable CD34(þ) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transpl. 2002;29:967–72.

3. Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, et al. Transplanted CD34(þ) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. Biol Blood Marrow Transpl. 2011;17:1146–53.

4. Ungerstedt JS, Watz E, Uttervall K, Johansson BM, Wahlin BE, Näsman P, et al. Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery. Med Oncol. 2012;29:2191–9.

5. Carlsten M, Jädersten M, Hellström A, Littmann K, Melén CM, Junlén HR, et al. The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016. Exp Hematol Oncol. 2019;8:7.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryostorage of peripheral blood hematopoietic stem cells in transplantology: current status and prospects;Cardiovascular Therapy and Prevention;2023-12-10

2. A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies;eJHaem;2023-03-02